Abstract
Conclusions: The common PNPLA3 polymorphism confers an increased risk of liver fibrosis in patients with chronic liver diseases. This observation can be attributed to the additive harmful effects of hepatic fat accumulation and inflammation in response to chronic liver injury. Our findings point to a novel non-invasive genetic screening strategy to identify patients with chronic liver diseases at risk for cirrhosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
